4CPS-152 Eculizumab for dense deposit disease: increased dosage without response: a case report

BACKGROUND: Dense deposit disease (DDD) is a rare glomerulonephritis caused by uncontrolled stimulation of the alternative complement pathway. Allograft survival after kidney transplantation is significantly reduced by the high rate of disease recurrence. No therapeutic interventions have consistent...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Eur J Hosp Pharm
Главные авторы: Ferreras, A Rodríguez, López, E Lázaro, García, I Zapico, Fernández, C Carriles, Blanc, R Menárguez, Martínez, A Arias, Tamames, B Zárate, López, A Pieras, Roces, L Velasco, Lozano-Blázquez, A
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Group 2018
Предметы:
Section 4: Clinical pharmacy services
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535363/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.243
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы